News

Opinion
MindSite News on MSN1hOpinion
Therabot Study Flawed and Biased
A psychologist writes to say that our report on a randomized clinical trial for Therabot, an AI therapy chatbot, overlooked methodological weaknesses and researcher bias.
In the first clinical trial of its kind, an A.I. chatbot eased mental health symptoms among participants. The technology may ...
Adults showed a significant reduction in their clinical-level mental health symptoms with unrestricted access to a generative ...
Breakthrough Dartmouth study crystallizes AI's capacity to curate services and spur business innovation. Ten tech readiness ...
Dartmouth's Therabot trial shows promising results for AI-assisted therapy, reducing depression symptoms by 51% and anxiety ...
But the organization says it's pleased with the rigorous clinical training that researchers invested in this model. "The ...
The study, which tested the effects of “Therabot” on symptoms of anxiety, depression and eating disorders, showed significant improvements among participants — comparable to outcomes seen in ...
You can reach Jon at [email protected] The study was published in March in the journal NEJM AI. Researchers conducted a trial ...
Researchers conducted a trial with 106 people who used Therabot, a smartphone app developed at Dartmouth over the past several years. It's a small sample, but the researchers said it's the first ...
Using a generative AI chatbot for mental health care can be risky, but an early study of a tool designed by Dartmouth researchers shows promise.
The study introduced Therabot, an AI-powered chatbot that has been designed to assist with mental health treatment. Therabot is a generative AI chatbot fine-tuned by experts to provide mental health ...